CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer

Abstract

Decreased CHIP expression in GC resulted in increased angiogenesis and contributed to GC progression and poor prognosis. CHIP expression is a GC candidate clinical prognostic marker and a putative treatment target.